Compare ARK Genomic Revolution ETF (ARKG) vs Snowflake Inc (SNOW) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Snowflake Inc — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while Snowflake Inc trades at $263 (market cap $90.62B). Which is the better fit depends on your goals.
| ARKG | SNOW | |
|---|---|---|
Sector | Sector/Thematic | Technology |
52-Week High | $43.57 | $280.16 |
52-Week Low | $23.09 | $121.11 |
Market Cap | — | $90.62B |
Enterprise Value | — | $90.44B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
Snowflake (SNOW) trades at $261.45, down 2.26% today but maintains strong technical momentum with bullish moving averages and a consensus price target of $294.31. The company shows impressive revenue growth from $1.2B in 2022 to $3.63B in 2025, though it remains unprofitable with a -23.79% net margin. Recent earnings beats and accelerating AI Data Cloud adoption signal strong business momentum despite premium valuation metrics.
Snowflake presents a growth-focused investment opportunity with 80.77% analyst buy ratings and projected revenue reaching $5B in 2026. Key risks include persistent losses, intense cloud competition, and premium valuation at 17.7x P/S ratio. The stock's upside depends on continued AI platform adoption and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Snowflake Inc
Founded in 2012, Snowflake is a data lake, warehousing, and sharing company that came public in 2020. To date, the company has over 3,000 customers including nearly 30% of the Fortune 500 as its customers. Snowflake's data lake stores unstructured and semistructured data that can then be used in analytics to create insights stored in its data warehouse. Snowflake's data sharing capability allows enterprises to easily buy and ingest data almost instantaneously compared with a traditionally months-long process. Overall, the company is known for the fact that all of its data solutions that can be hosted on various public clouds.
Read more on SNOW →
